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Istanbul, TurkeyAbstractThe strictly anaerobic Gram-negative bacteria Butyricimonas species have recently been described in human faeces and have to our knowledge
not been isolated in infectious clinical materials. We report the ﬁrst case of Butyricimonas virosa bacteraemia in a 72-year-old man with colon
adenocarcinoma, who underwent aortic aneurysm replacement surgery.
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E-mail: nulger@marmara.edu.trCase reportAnaerobic bacteraemia, accounting for 1–17% of all bacter-
aemia, mostly originates from endogenous microbiota, especially
in patients with malignancies (particularly colon cancer), hae-
matological disorders, immunodeﬁciency, recent gastrointestinal
or gynaecological surgery and advanced age. The mortality rate
of those infections remains high (15–35%), so early diagnosis and
appropriate treatment of these infections are critical [1,2].
We described a case of Butyricimonas virosa bacteraemia in a
72-year-old man. The patient with a previously diagnosed colonic
adenocarcinoma underwent aortic aneurysm surgery and suf-
fered fever (37.8 °C) 24 days after surgery. Blood and urine were
collected for culture, then, meropenem plus colistin was
administered empirically. The patient was transferred to the
intensive care unit because of septic shock on the following day.
Gram-negative rods isolated from anaerobic blood culture
bottles after a 72-h incubation period were obligate anaerobes,
catalase-producing, inhibited on Bacteroides bile aesculin agar, andNew Microbes and New Infections © 2015 The Authors. Published by El
This is an open access artiresistant to vancomycin (5 μg), kanamycin (1 mg) and colistin
sulphate (10 μg), suggesting that the isolate was a Prevotella
species. On Rapid ID 32A (bioMérieux, Marcy l’Etoile, France),
the isolate was positive for β-galactosidase, N-acetyl-β-glucosa-
minidase, glutamic acid decarboxylase, indole, alkaline phospha-
tase, leucyl glycine, alanine, glutamyl glutamic acid, arylamidases
and pyroglutamic acid arylamidase. However; both Rapid ID 32A
and matrix-assisted laser desorption/ionization time-of-ﬂight
(VITEK MS; bioMérieux) were insufﬁcient for identiﬁcation.
The 16S rRNA gene sequence of the strain showed 99% nucle-
otide identity to that of the strain Butyricimonas virosa isolated
from rat faeces (GenBank accession no. NR_041691.1). Inves-
tigation of the next most closely related species showed that our
strain exhibited 97%, 96% and 94% sequence similarity with
Butyricimonas paravirosa, Butyricimonas faecihominis and Butyr-
icimonas synergistica, respectively [3,4], (Fig. 1).
The bacterium did not produce β-lactamase when tested with
a nitroceﬁn disc (bioMérieux). Antibiotic susceptibilities were
determined by E-test (bioMérieux) on Brucella agar (Oxoid,
Basingstoke, UK) supplemented with 5% deﬁbrinated sheep
blood. The results showed sensitivity to ampicillin, sulbactam-
ampicillin, amoxicillin-clavulanic acid, piperacillin-tazobactam,
imipenem, meropenem, clindamycin and metronidazole.
Sakamoto et al. [3] ﬁrst characterized the species B. virosa, a
butyric acid-producing bacterium in the family Porphyr-
omonadaceae isolated from rat faeces. Having also 99% 16SNew Microbe and New Infect 2015; 4: 7–8
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FIG. 1. Neighbour-joining phylogenetic tree based on 16S rRNA gene sequences, showing the relationships between STRAIN MARMARA and some
related taxa. GenBank accession numbers are shown in parentheses. Numbers at nodes indicate bootstrap percentages (based on 1000 replicates). Bar
represents 0.02 substitutions per nucleotide position.
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obtained fromhuman faeces suggested that the isolatewas part of
the patient’s intestinal microbiota and his underlying bowel ma-
lignancy had created a predisposition for bacteraemia [5,6].
This is the ﬁrst case of human infection due to B. virosa
(GenBank accession number: BankIt1777481 Seq KP193456) in
the world literature. However, it may not reﬂect the actual
result because phenotypic characteristics resembling Prevotella
sp. may lead to misidentiﬁcation and identiﬁcation systems have
an insufﬁcient database for this microorganism.
The patient’s fever disappeared 3 days after administration of
antibiotic therapy. His clinical condition improved relatively and
he was followed up in the intensive care unit; however, he died
4 weeks later as the result of Acinetobacter septicaemia and a
potentially fatal condition resulting from multi-organ failure.
In conclusion, to discover the actual prevalence of B. virosa
infection, routine laboratories should re-evaluate the isolates
that are identiﬁed as Prevotella species.Conﬂict of interestNone declared.New Microbes and New Infections © 2015 The Authors. Published by Elsevier Ltd on behalf of
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